Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:800-801 (9 April), doi:10.1136/bmj.330.7495.800
Public confidence needs to be restored after concerns over the safety of SSRIs
| The first 150 words of the full text of this article appear below. |
Depression is a condition of "particular concern, which costs lives and affects the quality of life," according to UK prime minister Tony Blair.1 Nine out of 10 depressed patients are treated only in primary care,2
3 and up to two thirds of suicide victims contact a general practitioner in the four weeks before the death.4 For years, however, general practitioners have been criticised for failing to deal adequately with depression. Like hypertension, depression is subject to a rule of halvesonly half of depressed patients seek help from doctors, half are detected in primary care, half receive treatment with only half completing it: fewer than 10% finish a therapeutic course of treatment.5 A range of initiatives, often erroneously based on educational models for general practitioners, has aimed to improve detection rates and to increase the appropriateness of prescribing in depression with variable success, including a spectacular failure, in Hampshire, to influence
Andre Tylee, professor of primary care mental health
Health Services Research Department, Institute of Psychiatry, London SE5 8AF
Roger Jones, Wolfson professor of general practice
Department of General Practice and Primary Care, GKT School of Medicine, London SE11 6SP (roger.jones@kcl.ac.uk)
Read all Rapid Responses